Skip to main content

SITIME Corp

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

SITM$457.05+9.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1. The Company and Basis of Presentation

SiTime Corporation (the “Company” or "SiTime") was incorporated in the State of Delaware in December 2003. The Company is a leading provider of Precision timing ("Precision Timing") solutions, a category that SiTime created. Precision Timing provides the timing functionality that is needed for electronics to operate reliably and accurately. The Company's products have been designed to address a wide range of applications across a broad array of end markets. The Company operates a fabless business model and leverages its global network of distributors to address the broad set of end markets that it serves.

The accompanying interim condensed consolidated financial statements have been prepared in conformity with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X, and should be read in conjunction with the Company's audited consolidated financial statements and related notes thereto filed with the U.S. Securities and Exchange Commission ("SEC") on Form 10-K for the fiscal year ended December 31, 2024. The interim financial statements are unaudited, but reflect all adjustments which are, in the opinion of management, of a normal, recurring nature necessary to provide a fair statement of results for the interim periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ended December 31, 2025, for any future year, or for any other future interim period.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant areas requiring the use of management estimates and assumptions include revenue recognition, fair value of earnout liabilities, estimate of reserve for excess and obsolete inventories, and sales reserves. Actual results could differ from those estimates.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Significant Accounting Policies

The Company’s significant accounting policies are disclosed in the Company’s audited consolidated financial statements and related notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2024. There have been no changes to these accounting policies through September 30, 2025.

Recent Accounting Pronouncements

Recently issued accounting pronouncements not yet adopted

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The ASU requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. This ASU will likely result in the required additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The ASU requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires disclosure of the total amount of selling expenses along with the definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively to consolidated financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is also permitted. This ASU will likely result in the required additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.

Note 2. Net Loss Per Share

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(in thousands, except per share data)
Net loss attributable to common stockholders$(8,014)$(19,315)$(52,070)$(74,788)
Weighted average shares used to compute basic and diluted net loss per share26,04823,23724,55123,001
Net loss attributable to common stockholders per share, basic and diluted$(0.31)$(0.83)$(2.12)$(3.25)

Potential dilutive securities include dilutive common shares from share-based awards attributable to the restricted stock unit awards calculated using the treasury stock method. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.

Anti-dilutive potential shares from share-based awards are excluded from the calculation of diluted earnings per share if either their exercise price exceeded the average market price during the period, or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method. During the three months ended September 30, 2025 and 2024, the Company had 439,954 and 537,475 potential shares from restricted stock units that are anti-dilutive, respectively. During the nine months ended September 30, 2025 and 2024, the Company had 474,878 and 582,264 potential shares from restricted stock units that are anti-dilutive, respectively.

Note 3. Fair Value Measurements

Cash equivalents

At September 30, 2025 and December 31, 2024, highly liquid money market funds of $0.2 million and $0.3 million, respectively, were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets, and are included in cash equivalents.

Short-term investments in held-to-maturity securities

As of September 30, 2025 and December 31, 2024, the Company had purchased Treasury Bills with maturities ranging from 3 to 12 months, which the Company intends to hold until maturity and has classified as held-to-maturity securities. The held-to-maturity securities are recorded at amortized cost totaling $782.5 million including gross accrued interest of $7.5 million as of September 30, 2025. As of September 30, 2025, the fair value on the held-to-maturity securities was $782.7 million and the gross unrealized gain was $0.2 million.

As of December 31, 2024, the amortized cost of the held-to-maturity securities totaled $412.7 million including gross accrued interest of $4.3 million. As of December 31, 2024, the fair value and gross unrealized gain on the held-to-maturity securities was $412.9 million and $0.2 million, respectively.

These treasury bills were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets, and are included in short-term investments. The carrying value of our investments is reviewed quarterly for changes in circumstances or the occurrence of events that suggests an investment may not be fully recoverable.

Sales-based earnout liability

The estimated fair value of the sales-based earnout liability is determined using a Monte Carlo simulation model using significant unobservable fair value inputs and is therefore classified as a Level 3 measurement. The assumptions used in the calculation are based on the revenue projections over the term of the contingent earn-out period, expected volatility, and discount rate. The estimates of fair value are uncertain and changes in any of the estimated inputs used will result in significant adjustments to the fair value. As of September 30, 2025, the Company used a volatility rate of 20%, risk free rate ranging from 3.6% to 4.1%, and an expected term ranging from 0.13 years to 3.13 years.

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities:

Amount
Fair value as of January 1, 2025$97,256
Change in the fair value during the year recorded to acquisition related costs2,492
Payments made during the period(9,143)
Fair value as of September 30, 2025$90,605

There were no transfers between Level 1, Level 2, and Level 3 categories during any of the periods presented.

Note 4. Balance Sheet Components

Accounts Receivable, net

Accounts receivable, net consisted of the following:

As of
September 30, 2025December 31, 2024
(in thousands)
Accounts receivable, gross$22,554$38,259
Allowance for credit losses(50)(50)
Accounts receivable, net$22,504$38,209

Inventories

Inventories consisted of the following:

As of
September 30, 2025December 31, 2024
(in thousands)
Raw materials$21,856$14,995
Work in progress39,14947,300
Finished goods25,73814,446
Total inventories$86,743$76,741

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

As of
September 30, 2025December 31, 2024
(in thousands)
Prepaid expenses$4,762$4,305
Other current assets8,4165,971
Total prepaid expenses and other current assets$13,178$10,276

Property and Equipment, net

Property and equipment, net consisted of the following:

As of
September 30, 2025December 31, 2024
(in thousands)
Lab and manufacturing equipment$152,446$119,964
Computer equipment4,0183,833
Furniture and fixtures1,1771,167
Construction in progress10,4259,538
Leasehold improvements8,2867,818
176,352142,320
Accumulated depreciation(77,125)(59,845)
Total property and equipment, net$99,227$82,475

Depreciation expense related to property and equipment was $6.1 million and $4.0 million for the three months ended September 30, 2025 and 2024, respectively, and $17.1 million and $11.4 million for the nine months ended September 30, 2025 and 2024, respectively.

Intangible Assets, net

Intangible assets, net consisted of the following:

As of
September 30, 2025 · December 31, 2024
(in thousands)
Gross AssetsAccumulated AmortizationNet AssetsGross AssetsAccumulated AmortizationNet Assets
Developed technology$96,700$(20,186)$76,514$96,700$(10,575)$86,125
Contract based royalty asset5,900(2,704)3,1965,900(1,598)4,302
Internal use software———9,434(9,434)—
Purchased software15,783(12,856)2,92715,551(11,920)3,631
Total amortizable intangible assets$118,383$(35,746)$82,637$127,585$(33,527)$94,058
In-process research and development69,500—69,50069,500—69,500
Total intangible assets$187,883$(35,746)$152,137$197,085$(33,527)$163,558

Amortization expense for intangible assets was $3.8 million and $3.9 million for the three months ended September 30, 2025 and 2024, respectively, and $11.6 million and $10.0 million for the nine months ended September 30, 2025 and 2024, respectively.

The estimated aggregate future amortization expense for intangible assets subject to amortization as of September 30, 2025 is summarized as below:

(in thousands)
2025 (remainder)$3,842
202615,122
202714,750
202812,985
202911,127
2030 and beyond24,811
$82,637

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

As of
September 30, 2025December 31, 2024
(in thousands)
Accrued payroll and related benefits$11,289$12,381
Revenue reserves4,0203,673
Sales-based earnout liability, current29,48023,953
Acquisition consideration payable, current38,40037,760
Short term lease liability2,6602,744
Other accrued expenses5,9585,044
Total accrued expenses and other current liabilities$91,807$85,555

Other Non-current Liabilities

Other non-current liabilities consisted of the following:

As of
September 30, 2025December 31, 2024
(in thousands)
Sales-based earnout liability, non-current$61,125$73,303
Long term lease liability1,7753,488
Other non-current liabilities18—
Total other non-current liabilities$62,918$76,791

Note 5. Leases

The Company leases office space in California, Michigan, Malaysia, Japan, Taiwan, the Netherlands, Finland, Ukraine, and India, all under non-cancellable operating leases with various expiration dates through May 2029.

The remaining lease terms vary from a few months tofour years. For certain of its leases the Company has options to extend the lease term for periods varying fromone tofive years. These renewal options are not considered in the remaining lease term unless it is reasonably certain that the Company will exercise such options. The Company also has variable lease payments that are primarily comprised of common area maintenance and utility charges.

The table below presents the operating lease-related assets and liabilities recorded on the condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024:

As of
September 30, 2025December 31, 2024
(in thousands)
Right-of-use assets$4,871$6,569
Lease liabilities included in accrued expenses and other current liabilities2,6602,744
Lease liabilities included in other non-current liabilities1,7753,488
Total operating lease liabilities$4,435$6,232
Weighted-average remaining lease term (years)1.82.4
Weighted-average discount rate5.3%5.1%

The table below presents certain information related to the lease costs for operating leases for the three and nine months ended September 30, 2025 and 2024:

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2025202420252024
(in thousands)
Operating lease cost$824$794$2,451$2,295
Short-term lease cost2802361,252650
Variable lease cost9745822,7421,231
Total lease cost$2,078$1,612$6,445$4,176

Cash paid for operating lease liabilities was $0.9 million and $0.8 million for the three months ended September 30, 2025 and 2024, respectively, and $2.6 million and $2.4 million for the nine months ended September 30, 2025 and 2024, respectively.

Operating Lease Cash Flows

The table below reconciles the undiscounted cash flows for each of the first five years and total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of September 30, 2025:

(in thousands)
Remainder of 2025$858
20262,779
2027725
2028226
202984
Total minimum lease payments4,672
Less: amount of lease payments representing interest(237)
Present value of future minimum lease payments4,435
Less: current obligations under leases(2,660)
Long-term lease liabilities$1,775

Note 6. Stockholders’ Equity

At-The-Market offering

On February 27, 2024, the Company entered into a Sales Agreement ("Sales Agreement"), with Stifel, Nicolaus & Company, Incorporated ("Stifel"), under which the Company may offer and sell from time to time at its sole discretion, up to an aggregate of 1,200,000 shares of its common stock, par value $0.0001 per share, through Stifel acting as its sales agent.

During the three months ended September 30, 2025, the Company did not sell any shares of its common stock through Stifel under the Sales Agreement. During the three months ended September 30, 2024, the Company sold 100,000 shares of its common stock through Stifel under the Sales Agreement at a weighted average price of $137.85 per share resulting in net proceeds to the Company of $13.3 million, after deducting underwriting discounts and commissions of $0.3 million and offering costs of $0.2 million.

During the nine months ended September 30, 2025, the Company sold 150,000 shares of its common stock through Stifel under the Sales Agreement at a weighted average price of $203.94 per share resulting in net proceeds to the Company of $29.7 million, after deducting underwriting discounts and commissions of $0.6 million and deferred offering costs of $0.3 million. During the nine months ended September 30, 2024, the Company sold 232,500 shares of its common stock through Stifel under the Sales Agreement at a weighted average price of $126.93 per share resulting in net proceeds to the Company of $28.4 million, after deducting underwriting discounts and commissions of $0.6 million and deferred offering costs of $0.5 million.

Follow-on public offering

On June 27, 2025, the Company completed a follow-on public offering, in which it issued and sold 2,012,500 shares of its common stock, resulting in net proceeds to the Company of $387.3 million after deducting underwriting discounts and commissions of $14.1 million and deferred offering costs of $1.1 million.

Equity Incentive Plans

The following table summarizes the RSU, performance based restricted stock units ("PRSU"), and multi-year performance restricted stock units ("MYPSU") activity for the three and nine months ended September 30, 2025:

RSUNumberofSharesGrant DateFairValueper sharePRSUNumberofSharesGrant DateFairValueper shareMYPSUNumberofSharesGrant DateFairValueper share
Unvested at December 31, 2024915,152$128.7210,044$104.3285,880$88.6
Granted255,368173.9155,565187.8——
Vested(145,509)137.5(53,090)167.8——
Forfeited(16,236)113.3————
Unvested at March 31, 20251,008,775$139.1312,519$135.1285,880$88.6
Granted80,208167.9————
Vested(187,281)140.1————
Forfeited(13,782)165.8————
Unvested at June 30, 2025887,920$141.1312,519$135.1285,880$88.6
Granted63,122197.0————
Vested(159,573)148.2————
Forfeited(4,127)166.2————
Unvested at September 30, 2025787,342$143.9312,519$135.1285,880$88.6

The following summarizes the number and value of the shares withheld for employee taxes:

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2025202420252024
(in thousands, except share data)
Shares withheld for taxes62,57386,593204,952257,599
Amount withheld for taxes$13,984$12,198$41,269$32,566

In February 2025, the Compensation Committee approved target bonus amounts based on the achievement of revenue and individual performance goals for the fiscal year 2025 (the "2025 Goals"). The awards for the actual payouts are granted in the quarter following the end of the performance period. The target bonuses were granted based on a fixed dollar amount to be settled in RSUs on the vesting date and hence the awards have been classified as liability-based awards until settled. Such expense is included in the non-cash adjustment within stock-based compensation expense on the condensed consolidated cash flow statements. The liability of $4.2 million for 2025 Goals was recorded as accrued expenses and other current liabilities in the condensed consolidated balance sheet as of September 30, 2025.

In February 2025, the Compensation Committee of the Company approved PRSUs for the fiscal year 2025 with performance goals based on the achievement of relative total stockholder return with athree year performance period (the "2025 TSR PRSU Goals"). The grant-date fair value of each PRSU was determined using Monte Carlo simulation model. The assumptions used in the Monte Carlo simulation for the awards included expected volatility ranging from 72.6% to 72.9%, risk free rate of 4.3%, no expected dividend yield and expected term of 2.9 years. The Company recognizes the expense related to the 2025 TSR PRSU Goals on a graded-vesting method over the requisite performance period. These grants are included in the PRSU awards granted in the table above.

The Company also operates a bonus plan for certain employees which are based on a fixed dollar amount to be settled in RSUs. These awards are categorized as liability-based awards until settled. Once settled, these awards are reflected as RSU granted in the above table. Such expense is included in the non-cash adjustment within stock-based compensation expense on the condensed consolidated cash flow statements. The liability of $1.0 million was recorded as accrued expenses and other current liabilities in the condensed consolidated balance sheet as of September 30, 2025.

Stock-Based Compensation

The following table presents the detail of stock-based compensation expense amounts included in the condensed consolidated statement of operations for each of the periods presented:

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2025202420252024
(in thousands)
Equity based awards
Cost of revenue$740$470$2,134$961
Research and development10,0708,52630,27225,762
Selling, general and administrative13,08411,71039,50835,801
$23,894$20,706$71,914$62,524
Liability based awards - to be settled in equity
Cost of revenue$91$25$223$41
Research and development1,4158662,9382,220
Selling, general and administrative2,3571,2154,0532,646
$3,863$2,106$7,214$4,907
Total stock-based compensation expense - equity and liability based$27,757$22,812$79,128$67,431
Stock-based compensation expense recorded to additional paid-in capital
Equity based awards$23,894$20,706$71,914$62,524
Liability based awards - settled in equity9761,0098,4143,633
Stock-based compensation expense capitalized to inventory(159)200(338)1,005
Total stock-based compensation expense recorded to additional paid-in capital$24,711$21,915$79,990$67,162

The following table presents the unrecognized compensation costs and related weighted average period of recognition as of September 30, 2025:

Unrecognized Compensation Costs (in millions)Weighted Average Period of Recognition (in years)
RSUs$94.82.1
PRSUs$22.91.2
MYPSUs$0.50.3
Liability-based awards$6.10.5

Note 7. Income Taxes

The quarterly provision for income taxes is based on applying the estimated annual effective tax rate to the year to date pre-tax income, plus any discrete items. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income before income taxes, the geographic mix of income before income taxes and any significant permanent tax items.

The following table presents the provision for income taxes and the effective tax rates for the three and nine months ended September 30, 2025 and 2024:

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2025202420252024
(in thousands)
Loss before income taxes$(7,903)$(19,196)$(51,857)$(74,674)
Income tax expense(111)(119)(213)(114)
Effective tax rate1%1%0%0%

The Company’s effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in tax jurisdictions with different statutory rates, benefits related to tax credits and the tax impact of non-deductible expenses, existence of full valuation allowance on its deferred tax assets, and other permanent differences between income before income taxes and taxable income.

A valuation allowance is established or maintained when, based on currently available information and other factors, it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company regularly assesses its valuation allowance against deferred tax assets on a jurisdiction by jurisdiction basis. The Company considers all available positive and negative evidence, including future reversals of temporary differences, projected future taxable income, tax planning strategies and recent financial results. Based on management’s assessment of the realizability of deferred tax assets, the Company continues to maintain a full valuation allowance on its deferred tax assets as of September 30, 2025.

The income tax provision was immaterial for both the three and nine months ended September 30, 2025 and 2024. The provision for income taxes is primarily related to the foreign subsidiaries’ local country obligations. The U.S. effective tax rate is less than 1% and is due to minimum state tax. There is no federal provision for income taxes as the Company has sufficient carryforward of net operating losses to offset any operating income earned since inception and has projected an operating loss in the current year.

On July 4, 2025, the One Big Beautiful Bill Act (the “Act”) was enacted into law. The Company has evaluated the impact of the Act and determined that, due to its full valuation allowance, year-to-date and forecasted full-year taxable loss position, absence of Foreign-Derived Intangible Income and Global Intangible Low-Taxed Income, limitations under IRC Section 163(j), and the availability of pre-2017 net operating loss carryforwards, the Act does not have a material impact on the Company’s effective tax rate for both the three and nine months ended September 30, 2025. Accordingly, no discrete tax expense has been recorded for the period.

As of September 30, 2025 and December 31, 2024, the Company had $2.5 million and $2.5 million, respectively, of total unrecognized tax benefits. If the Company is able to eventually recognize these uncertain tax positions, none of the unrecognized benefits would reduce the Company’s effective tax rate due to the full valuation allowance on the Company’s deferred tax assets.

The Company’s policy is to record interest and penalties related to unrecognized tax benefits as income tax expense. For the three and nine months ended September 30, 2025 and 2024, the Company recorded immaterial amounts related to the accrual of interest and penalties.

Note 8. Segment, Geographic and Customer Information

The Company operates inone reportable segment related to the design, development, and sale of Precision Timing solutions to the global electronics industry.

The accounting policies of the Company’s single segment and key performance measures used by the Chief Executive Officer, who is the Chief Operating Decision Maker, to assess the performance of the Company are the same as those described within Note 1 and Note 11 of the Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 14, 2025.

The table below provides information about the Company’s revenue, significant segment expenses and other segment expenses.

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2025202420252024
(in thousands) · (in thousands)
Revenue$83,567$57,698$213,375$134,586
Less:
Product costs25,67218,09264,01141,476
Depreciation4,0712,03411,1095,743
Amortization3,5793,57710,7368,524
Other manufacturing overheads5,5284,52816,41410,193
Gross profit44,71729,467111,10568,650
Less:
Acquisition related costs1262,4823,5608,886
Interest income(8,275)(5,499)(16,832)(17,795)
Other segment items (a)60,88051,799176,447152,347
Net loss$(8,014)$(19,315)$(52,070)$(74,788)

(a)Other segment items include research and development expenses and selling, general and administrative expenses, primarily in the nature of nonmanufacturing expenses including salaries and stock-based compensation for employees, consulting expenses, certain other expenses, and taxes.

Revenue by geographic area is presented based upon the ship-to location of the customers who purchased the Company’s products, which may be different from the geographic locations of the ultimate end customers. The following table sets forth revenue by country for countries with 10% or more of the Company’s revenue during any of the periods presented:

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2025202420252024
(in thousands)
Hong Kong$28,458$17,010$75,854$42,546
Taiwan20,54120,85453,79642,465
Belgium9,965*12,736*
United States5,8693,79514,82011,428
Other18,73416,03956,16938,147
Total$83,567$57,698$213,375$134,586
  • Revenue from this geographical area was below 10%.

The following table sets forth the Company’s total property and equipment attributable to operations by country as of the periods presented:

As of
September 30, 2025December 31, 2024
(in thousands)
United States$31,455$32,200
Taiwan27,18624,294
Malaysia21,14016,231
Singapore12,5172,419
Other6,9297,331
$99,227$82,475

Note 9. Commitments and Contingencies

Legal Matters

From time to time, the Company may be a party to various litigation claims in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with legal counsel, the need to record a liability for litigation and contingencies. Accrual estimates are recorded when and if it is determined that such a liability for litigation and contingencies are both probable and reasonably estimable. We did not have any amounts accrued towards these matters as of September 30, 2025.

Indemnification

The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify other parties to such agreements with respect to certain matters. Typically, these obligations arise in the context of contracts that the Company has entered into, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants or terms and conditions related to such matters as the sale and/or delivery of its products, title to assets sold, certain intellectual property claims, defective products, and specified environmental matters. Further, the Company’s obligations under these agreements may be limited in terms of time, amount, or the scope of its responsibility and in some instances, the Company may have recourse against third-parties for certain payments made under these agreements. It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, the Company has had no material indemnification claims under these agreements.

Purchase Commitments

The Company purchases components from a variety of suppliers and uses several contract manufacturers to provide manufacturing services for its products. During the normal course of business, in order to manage manufacturing lead times and to help ensure adequate component supply, the Company enters into agreements with the Company’s contract manufacturers and suppliers that allow them to procure inventory based upon criteria as defined by the Company. In addition, the Company has a multi-year agreement to purchase minimum quantities of micro-electro-mechanical systems ("MEMS") wafers and is responsible for research and development, tooling, and samples cost under the agreement. A portion of the Company’s reported purchase commitments arising from these agreements consists of firm, non-cancelable purchase commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule, and adjust the Company’s requirements based on its business needs prior to when production starts. However, in situations where the Company is unable to cancel, reschedule, or adjust the purchase commitment due to changing customer demand, excess inventories could result in material inventory provisions. Total future non-cancelable purchase commitments as of September 30, 2025 were as follows:

(in thousands)
Remainder of 2025$4,653
20266,929
20274,993
202812,625
Total$29,200
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.